Lexaria Bioscience Corp. (LEXX)
10.54
-0.38
(-3.44%)
USD |
NASDAQ |
Aug 24, 16:00
10.54
0.00 (0.00%)
Pre-Market: 20:00
Lexaria Bioscience Market Cap : 17.42M for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 24, 2026 | 17.42M |
| August 21, 2026 | 18.04M |
| August 20, 2026 | 18.62M |
| August 19, 2026 | 19.02M |
| August 18, 2026 | 19.04M |
| August 17, 2026 | 17.05M |
| August 14, 2026 | 14.94M |
| August 13, 2026 | 13.39M |
| August 12, 2026 | 10.11M |
| August 11, 2026 | 9.568M |
| August 10, 2026 | 9.072M |
| August 07, 2026 | 8.709M |
| August 06, 2026 | 8.824M |
| August 05, 2026 | 9.370M |
| August 04, 2026 | 9.287M |
| August 03, 2026 | 7.849M |
| July 31, 2026 | 9.692M |
| July 30, 2026 | 9.823M |
| July 29, 2026 | 13.14M |
| July 28, 2026 | 200.81M |
| July 27, 2026 | 193.90M |
| July 24, 2026 | 207.84M |
| July 23, 2026 | 212.01M |
| July 22, 2026 | 207.99M |
| July 21, 2026 | 205.91M |
| Date | Value |
|---|---|
| July 20, 2026 | 223.09M |
| July 17, 2026 | 236.51M |
| July 16, 2026 | 207.99M |
| July 15, 2026 | 218.66M |
| July 14, 2026 | 218.33M |
| July 13, 2026 | 221.19M |
| July 10, 2026 | 240.41M |
| July 09, 2026 | 228.66M |
| July 08, 2026 | 224.94M |
| July 07, 2026 | 197.17M |
| July 06, 2026 | 208.03M |
| July 02, 2026 | 208.25M |
| July 01, 2026 | 212.67M |
| June 30, 2026 | 208.21M |
| June 29, 2026 | 211.45M |
| June 26, 2026 | 197.06M |
| June 25, 2026 | 203.38M |
| June 24, 2026 | 203.38M |
| June 23, 2026 | 211.00M |
| June 22, 2026 | 216.69M |
| June 18, 2026 | 200.85M |
| June 17, 2026 | 226.99M |
| June 16, 2026 | 219.00M |
| June 15, 2026 | 225.32M |
| June 12, 2026 | 228.48M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Target Group, Inc. (Canada) | 0.6417M |
| InMed Pharmaceuticals, Inc. | 4.739M |
| NervGen Pharma Corp. | 212.83M |
| Milestone Pharmaceuticals, Inc. | 129.48M |
| Clearmind Medicine, Inc. | 1.712M |
Market Cap Related Metrics
| PS Ratio | 81.66 |
| Price to Book Value | 3.676 |
| Price | 10.54 |
| Earnings Yield | -50.10% |